Cronos Group Inc (CRON)
Toronto Exchange · Canada · prices in CAD · close of 23 Oct 2026
Key indicators
| Last close | CAD 4.690 |
|---|---|
| 52-week range | 3.230 – 4.990 |
| Return, 1 month / 3 months | −2.5% / +20.9% |
| Return, 1 year / 3 years | +35.5% / +97.1% |
| Trend | Uptrend |
| RSI (14) | 54 |
| Volatility (1 year) | 40.2% |
| Worst drawdown (1 year) | -26.3% |
| Average daily value traded | 0.66M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cronos Group is a cannabis company based in Canada that cultivates, produces and sells cannabis products. Its offerings include dried cannabis flower, pre-rolled joints, oils and other derivative products, sold under consumer brands to adult-use customers and to patients through medical channels. The company also pursues international markets, including through subsidiaries and partnerships in other countries, and maintains production facilities in Canada. Its products reach consumers through licensed retailers and online channels where permitted.
The shares are listed on the Toronto Exchange in Canada under the code CRON, and the price on this page is in Canadian dollars (CAD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cronos Group Inc (CRON) trades on the Toronto Exchange in Canada. It last closed at CAD 4.690 on 23 October 2026.
Its price-based Market X-Ray is 71 out of 100 (a strong price profile), ranking 113 of 870 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 35.5% and over the last three months it rose 20.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Toronto Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 87 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 19.0% | ||
| From 52-week high | -5.3% | ||
| Momentum | 85 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 20.9% | ||
| 6-month return | 32.9% | ||
| 12-month return, skipping the last month | 39.0% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 40.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -26.3% | ||
| Liquidity | 48 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.66M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +2.9% |
|---|---|
| 1 month | −2.5% |
| 3 months | +20.9% |
| 6 months | +32.9% |
| 1 year | +35.5% |
| 3 years | +97.1% |
| 5 years | −32.6% |
Signals
| 50-day / 200-day average | 4.606 / 3.941 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.137 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Toronto Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.